PF-06372865 in Subjects With Photosensitive Epilepsy

NCT02564029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflex Epilepsy, Photosensitive

Interventions

DRUG: PF-06372865
DRUG: Placebo
DRUG: Lorazepam

Sponsor

Pfizer